Characteristics and determinants of adiposity in pediatric cancer survivors.
about
Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementRecruitment feasibility to a cohort study of endocrine and metabolic health among survivors of childhood brain tumours: a report from the Canadian study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE).Cardiovascular disease in adult survivors of childhood cancer.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Body composition after bone marrow transplantation in childhood.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.Cardiac failure 30 years after treatment containing anthracycline for childhood acute lymphoblastic leukemiaThe effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol.Premature Atherosclerotic Cardiovascular Disease in Childhood Cancer Survivors.Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors studyCanadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumoursAssessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trialAdiposity in childhood brain tumors: A report from the Canadian Study of Determinants of Endometabolic Health in Children (CanDECIDE Study).Pretreatment and routine echocardiogram monitoring during chemotherapy for anthracycline-induced cardiotoxicity rarely identifies significant cardiac dysfunction or alters treatment decisions: a 5-year review at a single pediatric oncology center.An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.Treatment-related cardiotoxicity in survivors of childhood cancer.Anthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatment.Prevention of cardiotoxicity among survivors of childhood cancer.Late Cardiotoxicity: Issues for Childhood Cancer Survivors.Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age-matched control study.Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study.
P2860
Q24628695-231B803D-6D86-4F82-BB0D-90E7172EF640Q30582316-7C680B07-CFE7-4D94-B723-24983F1B5074Q34042984-70F78310-D3E0-48DE-9A93-4C6F0BD175F2Q34572109-027F25EE-B6A7-43E5-93DD-FD4B0BD4295BQ34608891-A4B3A7A9-5038-4639-BD4B-1848287D06A6Q34626238-BE5874C9-CB0B-48F6-86D8-BD519CD41A40Q35562745-554D2ADA-CFEA-48A6-83BD-F741CF528182Q35925270-165465CB-602B-43BF-99EE-DE0D37417BD9Q36029249-24273E1B-C9A5-41EC-865D-0A72AE744C3BQ36049496-65984946-1613-4D43-918B-8392C3DAA160Q36052329-79A7222D-6BB1-4707-9ABF-5F710BCF480FQ36498620-A2D5A12A-3B8A-4AC4-9C33-256116B1338CQ36674961-CFDA39AE-3875-4E7E-AAC9-39D6D6B91B7DQ36939200-4F37AF0D-1B80-4F9C-A3BA-ACD56AF90101Q37129069-C7A66915-8A33-4CCD-A205-1613BB8C3C3CQ37714966-7BEB2A7E-A1B3-4135-A9D4-5098CE45F00AQ37924696-72CE5B42-3BF0-45B5-8FB5-2D82BACFC33DQ38109236-50ADD517-5513-4685-BA96-29A1221EC113Q38156036-73BAEB86-373B-4AF7-BB6B-9BE90418C2E3Q38205702-D202EDE6-09FB-4C5C-8962-744B92460B61Q38824644-A3D10C6D-8814-429E-918D-6E5E0B08D6E6Q38845457-B28D27E0-A75A-40A5-8337-A49FC8701F3CQ40652888-90D8A6DE-A809-4134-89F8-2F0A0FFAEEC0Q50480772-86248E5A-A33C-4914-A3FA-D6CAAC11CD18
P2860
Characteristics and determinants of adiposity in pediatric cancer survivors.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Characteristics and determinants of adiposity in pediatric cancer survivors.
@en
type
label
Characteristics and determinants of adiposity in pediatric cancer survivors.
@en
prefLabel
Characteristics and determinants of adiposity in pediatric cancer survivors.
@en
P2093
P2860
P1476
Characteristics and determinants of adiposity in pediatric cancer survivors
@en
P2093
Amy Rovitelli
Andrea S Hinkle
Carol French
Cynthia Proukou
Gabriela Lopez-Mitnik
Louis S Constine
Steven E Lipshultz
Stuart R Lipsitz
Tracie L Miller
P2860
P304
P356
10.1158/1055-9965.EPI-10-0163
P577
2010-07-20T00:00:00Z